Large-scale testing (Phase 3)UnknownNCT00790283What this trial is testingAssessment of the Numen Stent With Evaluation in a Randomized StudyWho this might be right forLesion International Biomedical Systems S.p.A. 500
Not applicableStudy completedNCT01425281What this trial is testingABSORB II Randomized Controlled TrialWho this might be right forCoronary Artery Disease Abbott Medical Devices 501
Not applicableStudy completedNCT00217256What this trial is testingThe Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical TrialWho this might be right forCoronary Artery Disease Medtronic Vascular 436
Not applicableStudy completedNCT01687075What this trial is testingCRE8 in All Comers PatientsWho this might be right forConsecutive Subjects Who Are Suitable for a CoronaryAngioplasty of de Novo Lesion(s) in Native CoronaryArteries Should be Screened for Eligibility.+3 more Tel-Aviv Sourasky Medical Center 215
Not applicableStudy completedNCT00300131What this trial is testingABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical InvestigationWho this might be right forCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis Abbott Medical Devices 30
Testing effectiveness (Phase 2)Study completedNCT00233714What this trial is testingDouble or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery LesionsWho this might be right forCoronary Artery Disease Cordis US Corp. 56
Not applicableStudy completedNCT00792753What this trial is testingElixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"Who this might be right forCoronary Artery Disease Elixir Medical Corporation 360
Post-approval studies (Phase 4)Study completedNCT04483791What this trial is testingDynamX Bioadaptor Hong Kong RegistryWho this might be right forCoronary Artery Disease Elixir Medical Corporation 50
Large-scale testing (Phase 3)Study completedNCT00180310What this trial is testingSPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent SystemWho this might be right forCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis Abbott Medical Devices 300
Not applicableUnknownNCT01960504What this trial is testingFirst in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)Who this might be right forCoronary Artery DiseaseCoronary Artery Stenosis Biotronik AG 123
Testing effectiveness (Phase 2)Study completedNCT00233805What this trial is testingThe Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.Who this might be right forCoronary Artery Disease Cordis US Corp. 220
Not applicableLooking for participantsNCT06959524What this trial is testingAGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsWho this might be right forCoronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries Boston Scientific Corporation 1,616
Large-scale testing (Phase 3)Study completedNCT00322569What this trial is testingA Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)Who this might be right forCoronary Disease Cordis US Corp. 246
Large-scale testing (Phase 3)Ended earlyNCT00322543What this trial is testingReduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)Who this might be right forCoronary Disease Conor Medsystems 3
Large-scale testing (Phase 3)Study completedNCT00180453What this trial is testingSPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent SystemWho this might be right forCoronary Artery DiseaseEverolimusVascular Disease+2 more Abbott Medical Devices 60
Testing effectiveness (Phase 2)Study completedNCT00248066What this trial is testingSafety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary ArteriesWho this might be right forCoronary Artery DiseaseCoronary Restenosis Sarepta Therapeutics, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00739466What this trial is testingBiorest Liposomal Alendronate With Stenting sTudy (BLAST)Who this might be right forCoronary Artery Stenosis BIOrest Ltd. 226
Not applicableEnded earlyNCT04375085What this trial is testingDESyne X2 Post Market Follow-up StudyWho this might be right forCoronary Artery Disease Elixir Medical Corporation 49
Not applicableStudy completedNCT01761578What this trial is testingARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable StentWho this might be right forCoronary Artery Disease Arterial Remodeling Technologies 30
Not applicableStudy completedNCT02716220What this trial is testingPre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)Who this might be right forCoronary Artery DiseaseCoronary Artery Stenosis Biotronik AG 61